Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Efficacy and Safety of Golimumab as Add-on Therapy to Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: Results of the GO-MORE Study in Spain
Eficacia y seguridad de golimumab añadido a fármacos antirreumáticos modificadores de la enfermedad en artritis reumatoide. Resultados del estudio GO-MORE en España
Alberto Alonsoa, Carlos M. Gonzálezb, Javier Ballinac, María L. García Vivard, Juan J. Gómez-Reinoe, Jose Luis Marencof, Antonio Fernández-Nebrog, Carmen Ordásh, Luis Cea-Calvoi,
Corresponding author
luis.cea@merck.com

Corresponding author.
, María J. Arteagai, Raimon Sanmartíj
a Departamento de Reumatología, Hospital de Cruces, Barakaldo, Vizcaya, Spain
b Departamento de Reumatología, Hospital Universitario Gregorio Marañón, Madrid, Spain
c Departamento de Reumatología, Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain
d Departamento de Reumatología, Hospital Universitario de Basurto, Bilbao, Vizcaya, Spain
e Departamento de Reumatología, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, A Coruña, Spain
f Departamento de Reumatología, Hospital Universitario de Valme, Sevilla, Spain
g Departamento de Reumatología, Hospital Regional Carlos Haya, Universidad de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain
h Departamento de Reumatología, Hospital de Cabueñes, Gijón, Asturias, Spain
i Departamento de Medical Affairs, Merck Sharp & Dohme de Spain, Spain
j Hospital Clínic i Provincial, Barcelona, Spain
Ver más
Read
6434
Times
was read the article
2365
Total PDF
4069
Total HTML
Share statistics
Article information
ISSN: 21735743
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 53 54 107
2024 October 86 17 103
2024 September 81 30 111
2024 August 61 39 100
2024 July 99 31 130
2024 June 54 31 85
2024 May 73 42 115
2024 April 42 26 68
2024 March 53 37 90
2024 February 25 18 43
2024 January 35 26 61
2023 December 17 37 54
2023 November 30 32 62
2023 October 37 30 67
2023 September 79 36 115
2023 August 48 17 65
2023 July 32 27 59
2023 June 32 32 64
2023 May 43 21 64
2023 April 18 9 27
2023 March 60 34 94
2023 February 64 29 93
2023 January 31 16 47
2022 December 72 41 113
2022 November 61 37 98
2022 October 59 33 92
2022 September 32 39 71
2022 August 29 32 61
2022 July 33 40 73
2022 June 42 36 78
2022 May 40 71 111
2022 April 48 43 91
2022 March 45 65 110
2022 February 29 22 51
2022 January 49 39 88
2021 December 42 46 88
2021 November 59 57 116
2021 October 69 72 141
2021 September 69 40 109
2021 August 36 38 74
2021 July 44 40 84
2021 June 51 51 102
2021 May 49 44 93
2021 April 118 110 228
2021 March 53 24 77
2021 February 42 24 66
2021 January 38 26 64
2020 December 34 20 54
2020 November 30 23 53
2020 October 31 18 49
2020 September 26 34 60
2020 August 24 22 46
2020 July 25 19 44
2020 June 38 24 62
2020 May 33 23 56
2020 April 28 20 48
2020 March 13 7 20
2020 February 1 0 1
2018 May 6 1 7
2018 April 50 10 60
2018 March 136 11 147
2018 February 30 3 33
2018 January 29 12 41
2017 December 38 13 51
2017 November 49 15 64
2017 October 50 11 61
2017 September 42 12 54
2017 August 32 9 41
2017 July 42 10 52
2017 June 65 12 77
2017 May 59 23 82
2017 April 58 21 79
2017 March 37 15 52
2017 February 33 6 39
2017 January 28 11 39
2016 December 70 18 88
2016 November 52 16 68
2016 October 101 11 112
2016 September 102 12 114
2016 August 65 12 77
2016 July 38 9 47
2015 December 3 0 3
2015 November 1 13 14
2015 October 1 23 24
2015 September 2 0 2
2015 August 2 26 28
2015 July 33 12 45
2015 June 70 20 90
2015 May 100 47 147
Show all

Follow this link to access the full text of the article

Idiomas
Reumatología Clínica (English Edition)
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?